InvestorsHub Logo

KMBJN

07/10/20 4:21 PM

#309908 RE: cybermich #309896

I think someone should tell the company to stop referring them as a RBL and a PHRI, if it is truly two RBLs. It's all a secret until the publications come out anyways, and then we will know who is doing the preclinical work, and what they discovered for brilacidin against SARS2 in a dish. Should be very good news if the rest of the results are as promising as the initial results we heard about so far!